Baseline characteristics were not significantly different according to radiation therapy, except age, BCLC tumor stage, macrovascular invasion, prothrombin time, and neutrophil-to-lymphocyte ratio (NLR) in the total and non-high-risk populations (Tables S1 and S2). The gene discussed is F2; the disease is neoplasm.